Table 2.
Category | Term | Description | Count in gene set | FDR |
---|---|---|---|---|
BP term | GO:0043062 | Extracellular structure organization | 16 | 4.18E−12 |
BP term | GO:0030198 | Extracellular matrix organization | 14 | 1.48E−10 |
BP term | GO:0030199 | Collagen fibril organization | 8 | 5.17E−10 |
BP term | GO:0071229 | Cellular response to acid chemical | 7 | 8.90E−04 |
BP term | GO:0001568 | Blood vessel development | 9 | 2.90E−03 |
CC term | GO:0005583 | Fibrillar collagen trimer | 6 | 1.18E−09 |
CC term | GO:0044420 | Extracellular matrix component | 7 | 4.25E−08 |
CC term | GO:0044421 | Extracellular region part | 18 | 1.41E−06 |
CC term | GO:0031012 | Extracellular matrix | 9 | 5.15E−06 |
CC term | GO:0062023 | Collagen-containing extracellular matrix | 7 | 7.99E−06 |
MF term | GO:0048407 | Platelet-derived growth factor binding | 4 | 2.78E−05 |
MF term | GO:0004497 | Monooxygenase activity | 4 | 7.50E−03 |
MF term | GO:0005201 | Extracellular matrix structural constituent | 4 | 7.50E−03 |
MF term | GO:0016404 | 15-Hydroxyprostaglandin dehydrogenase (NAD+) activity | 2 | 7.50E−03 |
MF term | GO:0043167 | Ion binding | 32 | 7.50E−03 |
KEGG pathway | hsa04974 | Protein digestion and absorption | 5 | 5.80E−04 |
RCTM pathway | HSA-1474244 | Extracellular matrix organization | 12 | 1.59E−08 |
RCTM pathway | HSA-3000178 | ECM proteoglycans | 8 | 1.59E−08 |
RCTM pathway | HSA-3000170 | Syndecan interactions | 6 | 3.17E−08 |
RCTM pathway | HSA-1442490 | Collagen degradation | 7 | 8.18E−08 |
RCTM pathway | HSA-216083 | Integrin cell surface interactions | 7 | 3.53E−07 |
BP: biological process; CC: cellular component; DEGs: differentially expressed genes; GO: gene ontology; KEGG: Kyoto encyclopedia of genes and genomes; MF: molecular function; RCTM: Reactome.